Arrhythmia Pharmacogenomics: Methodological Considerations

E-ISSN： 1873-4286|15|32|3734-3741

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.32, 2009-11, pp. : 3734-3741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics: implications and considerations for pharmacists

By Brock Tina Penick Valgus John M Smith Scott R Summers Kelly M

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 321-330

Future Medicine

Access to resources Recommend Favorite

Ethical considerations in clinical pharmacogenomics research

By Issa A.M.

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 247-249

Elsevier

Access to resources Recommend Favorite

Race, Distributive Justice and the Promise of Pharmacogenomics: Ethical Considerations

By Lee S.S-J.

American Journal of PharmacoGenomics, Vol. 3, Iss. 6, 2003-01 ,pp. : 385-392

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of CYP3A: considerations for HIV treatment

By Lakhman Sukhwinder S Ma Qing Morse Gene D

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1323-1339

Future Medicine

Access to resources Recommend Favorite

The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations

By Jönsson Linus

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 391-403

Adis International

Access to resources Recommend Favorite